Chemistry:MALT (psychedelic drug)

Short description: Chemical compound

MALT

Clinical data
Other names	N,N-Methylallyltyptamine; (2-(1H-Indol-3-yl)ethyl)(methyl)(prop-2-en-1-yl)amine; 1H-Indole-3-ethanamine, N-methyl-N-2-propen-1-yl-; Malt
Legal status
Legal status	UK: Class A US: Analogue to a Schedule I/II drug
Identifiers
IUPAC name N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine
CAS Number	1366416-29-6
PubChem CID	155907915
ChemSpider	74902443
UNII	R3PSM6BEG8
Chemical and physical data
Formula	C14H18N2
Molar mass	214.312 g·mol−1
3D model (JSmol)	Interactive image
SMILES CN(CCC1=CNC2=CC=CC=C21)CC=C
InChI InChI=1S/C14H18N2/c1-3-9-16(2)10-8-12-11-15-14-7-5-4-6-13(12)14/h3-7,11,15H,1,8-10H2,2H3 Key:GXCLVBGFBYZDAG-UHFFFAOYSA-N

MALT crystals

MALT (N-methyl-N-allyltryptamine or N,N-methylallyltryptamine) is a lesser-known drug from the tryptamine family. It is a novel compound with very little history of human use. It is closely related to methylpropyltryptamine (MPT), as well as N-methyltryptamine. It has been sold online as a designer drug. Very little information on the pharmacology or toxicity of MALT is available.

Legality

MALT is not explicitly scheduled in any countries; however, it could be considered a psychoactive substance under the UK Psychoactive Substances Act, which requires the prosecutor to prove that the substance is psychoactive in order for a person to be charged with an offense.

It could also be considered a structural analog of a scheduled substance under the US Federal Analogue Act due to its similarity to scheduled tryptamines.

See also

• 5-Methoxy-N,N-Methylallyltryptamine (5-MeO-MALT)
• N,N-Diallyltryptamine (DALT)
• Methylpropyltryptamine (MPT)

Further reading

• "DMT analogues: N-ethyl-N-propyl-tryptamine and N-allyl-N-methytryptamine as their hydro-fumarate salts". Acta Crystallographica Section E: Crystallographic Communications 76 (Pt 8): 1201–1205. August 2020. doi:10.1107/S2056989020008683. PMID 32843999. 
• "Analytical chemistry of synthetic routes to psychoactive tryptamines. Part I. Characterisation of the Speeter and Anthony synthetic route to 5-methoxy-N,N-diisopropyltryptamine using ESI-MS-MS and ESI-TOF-MS". The Analyst 129 (11): 1047–1057. November 2004. doi:10.1039/b407239c. PMID 15508033. Bibcode: 2004Ana...129.1047B.